Search - tctmd.com

Displaying 781 - 800 of 1424

Sort: Relevancy | Date

News Daily News

Meta-analysis: PCI Adds No Benefit to Medical Therapy in Patients with Proven Ischemia

Yael L. Maxwell

December 08, 2013

News Daily News

Post Angiography Testosterone Therapy Increases Cardiovascular Events in High-Risk Men

December 05, 2013

News Daily News

El Tratamiento con Testosterona Post-Angiografía aumenta los Episodios Cardiovasculares en Varones de Alto Riesgo

December 05, 2013

News Daily News

In-transit Preconditioning Study Shows Neutral Effect in Stroke Patients

L.A. McKeown

November 25, 2013

News Conference News AHA 2013

AHA 2013: Mix of Positive, Negative Trials Help Guide Interventional Practice

November 24, 2013

News Conference News AHA 2013

French Registry: FFR Safely Reclassifies Almost Half of Revascularization Patients

Yael L. Maxwell

November 20, 2013

News Conference News AHA 2013

Endovascular Revascularization Benefits PAD Patients When Added to Exercise Therapy

Yael L. Maxwell

November 18, 2013

News Conference News AHA 2013

Renal Stenting Fails to Improve Outcomes vs. Medical Therapy Alone in RAS Patients

Jason Kahn

November 17, 2013

News Conference News AHA 2013

Varying Cell Therapy Techniques Demonstrate Safety, Mixed Efficacy at AHA 2013

November 17, 2013

News Daily News

SCAI Paper Outlines ‘Best Practices’ for FFR, IVUS, OCT

Yael L. Maxwell

November 14, 2013

Presentation

Association of Testosterone Therapy with Mortality, MI, and Stroke in Men with Low Testosterone Levels

Presenter: R. Vigen

November 10, 2013

News Conference News TCT 2013

High-Dose Statins before PCI Improved Outcomes in NSTE-ACS

November 06, 2013

News Conference News TCT 2013

TAVR a Viable Option for Intermediate-Risk Patients

November 05, 2013

News Conference News TCT 2013

Pulmonary Artery Denervation Procedure May Improve Hemodynamic Outcomes in PAH

November 05, 2013

News Daily News

SCAI Proposes New Definition for Periprocedural MI

November 01, 2013

Presentation TCT 2013

TRANSLATE-POPS: A Prospective, Cluster-Randomized Trial of Routine Platelet Function Testing in Patients Undergoing PCI

Presenter: Tracy Wang

October 31, 2013

Presentation TCT 2013

Platelet Function Testing is of Clear Clinical Utility in Selected Patients

Presenter: Paul Gurbel

October 31, 2013

Presentation TCT 2013

Platelet Function and Genetic Testing are Currently Worthless

Presenter: Daniel Simon

October 31, 2013

Presentation TCT 2013

Genetic Testing is of Clear Clinical Utility in Selected Patients

Presenter: Jessica Mega

October 31, 2013

Presentation TCT 2013

Genetic Testing for 9p21 can Cost Effectively Reduce Cardiovascular Events

Presenter: James Devlin

October 31, 2013

Advertisement

Meta-analysis: PCI Adds No Benefit to Medical Therapy in Patients with Proven Ischemia

Post Angiography Testosterone Therapy Increases Cardiovascular Events in High-Risk Men

El Tratamiento con Testosterona Post-Angiografía aumenta los Episodios Cardiovasculares en Varones de Alto Riesgo

In-transit Preconditioning Study Shows Neutral Effect in Stroke Patients

AHA 2013: Mix of Positive, Negative Trials Help Guide Interventional Practice

French Registry: FFR Safely Reclassifies Almost Half of Revascularization Patients

Endovascular Revascularization Benefits PAD Patients When Added to Exercise Therapy

Renal Stenting Fails to Improve Outcomes vs. Medical Therapy Alone in RAS Patients

Varying Cell Therapy Techniques Demonstrate Safety, Mixed Efficacy at AHA 2013

SCAI Paper Outlines ‘Best Practices’ for FFR, IVUS, OCT

Association of Testosterone Therapy with Mortality, MI, and Stroke in Men with Low Testosterone Levels

High-Dose Statins before PCI Improved Outcomes in NSTE-ACS

TAVR a Viable Option for Intermediate-Risk Patients

Pulmonary Artery Denervation Procedure May Improve Hemodynamic Outcomes in PAH

SCAI Proposes New Definition for Periprocedural MI

TRANSLATE-POPS: A Prospective, Cluster-Randomized Trial of Routine Platelet Function Testing in Patients Undergoing PCI

Platelet Function Testing is of Clear Clinical Utility in Selected Patients

Platelet Function and Genetic Testing are Currently Worthless

Genetic Testing is of Clear Clinical Utility in Selected Patients

Genetic Testing for 9p21 can Cost Effectively Reduce Cardiovascular Events

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content